+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergy Relieving Eye Drops Market 2024-2028

  • PDF Icon

    Report

  • 141 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5654514
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The allergy relieving eye drops market is forecasted to grow by USD 373.2 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the allergy relieving eye drops market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence and incidence of eye infections, expanded geriatric populace, and increased prevalence of allergic conjunctivitis.

The allergy relieving eye drops market is segmented as below:

By Product

  • Antihistamines
  • Non-steroidal anti-Inflammatory drugs
  • Vasoconstrictors
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing adoption of generics as one of the prime reasons driving the allergy relieving eye drops market growth during the next few years. Also, high cost of prescription drugs and ascend in mindfulness about eye-related disorders will lead to sizable demand in the market.

The report on the allergy relieving eye drops market covers the following areas:

  • Allergy relieving eye drops market sizing
  • Allergy relieving eye drops market forecast
  • Allergy relieving eye drops market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy relieving eye drops market vendors that include AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Dr Reddys Laboratories Ltd., Johnson and Johnson Services Inc., Lupin Ltd., Nicox S.A., Novartis AG, Ocular Therapeutix Inc, Pfizer Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co. Ltd, Rynel Clifton Pharma Pvt. Ltd., Santen Pharmaceutical Co. Ltd., Similasan Corp. USA, Starpharma Holdings Ltd, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the allergy relieving eye drops market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Allergy Relieving Eye Drops Market 2018 - 2022
Historic Market Size - Data Table on Global Allergy Relieving Eye Drops Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Antihistamines - Market size and forecast 2023-2028
Chart on Antihistamines - Market size and forecast 2023-2028 ($ million)
Data Table on Antihistamines - Market size and forecast 2023-2028 ($ million)
Chart on Antihistamines - Year-over-year growth 2023-2028 (%)
Data Table on Antihistamines - Year-over-year growth 2023-2028 (%)
6.4 Non-steroidal anti-Inflammatory drugs - Market size and forecast 2023-2028
Chart on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2023-2028 ($ million)
Chart on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2023-2028 (%)
Data Table on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2023-2028 (%)
6.5 Vasoconstrictors - Market size and forecast 2023-2028
Chart on Vasoconstrictors - Market size and forecast 2023-2028 ($ million)
Data Table on Vasoconstrictors - Market size and forecast 2023-2028 ($ million)
Chart on Vasoconstrictors - Year-over-year growth 2023-2028 (%)
Data Table on Vasoconstrictors - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
11.4 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
11.5 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
11.6 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
11.7 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
11.8 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.9 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.10 Santen Pharmaceutical Co. Ltd.
Santen Pharmaceutical Co. Ltd. - Overview
Santen Pharmaceutical Co. Ltd. - Product / Service
Santen Pharmaceutical Co. Ltd. - Key offerings
11.11 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key news
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
11.12 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Allergy Relieving Eye Drops Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Antihistamines - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Antihistamines - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Antihistamines - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Antihistamines - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Vasoconstrictors - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Vasoconstrictors - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Vasoconstrictors - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Vasoconstrictors - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 50: Market opportunity by Product ($ million)
Exhibits 51: Data Table on Market opportunity by Product ($ million)
Exhibits 52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 53: Chart on Market share by geography 2023-2028 (%)
Exhibits 54: Data Table on Market share by geography 2023-2028 (%)
Exhibits 55: Chart on Geographic comparison
Exhibits 56: Data Table on Geographic comparison
Exhibits 57: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 93: Market opportunity by geography ($ million)
Exhibits 94: Data Tables on Market opportunity by geography ($ million)
Exhibits 95: Impact of drivers and challenges in 2023 and 2028
Exhibits 96: Overview on criticality of inputs and factors of differentiation
Exhibits 97: Overview on factors of disruption
Exhibits 98: Impact of key risks on business
Exhibits 99: Companies covered
Exhibits 100: Matrix on companies position and classification
Exhibits 101: AbbVie Inc. - Overview
Exhibits 102: AbbVie Inc. - Product / Service
Exhibits 103: AbbVie Inc. - Key news
Exhibits 104: AbbVie Inc. - Key offerings
Exhibits 105: Astellas Pharma Inc. - Overview
Exhibits 106: Astellas Pharma Inc. - Product / Service
Exhibits 107: Astellas Pharma Inc. - Key news
Exhibits 108: Astellas Pharma Inc. - Key offerings
Exhibits 109: Bausch Health Companies Inc. - Overview
Exhibits 110: Bausch Health Companies Inc. - Business segments
Exhibits 111: Bausch Health Companies Inc. - Key news
Exhibits 112: Bausch Health Companies Inc. - Key offerings
Exhibits 113: Bausch Health Companies Inc. - Segment focus
Exhibits 114: Dr Reddys Laboratories Ltd. - Overview
Exhibits 115: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 116: Dr Reddys Laboratories Ltd. - Key news
Exhibits 117: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 118: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 119: Johnson and Johnson Services Inc. - Overview
Exhibits 120: Johnson and Johnson Services Inc. - Business segments
Exhibits 121: Johnson and Johnson Services Inc. - Key news
Exhibits 122: Johnson and Johnson Services Inc. - Key offerings
Exhibits 123: Johnson and Johnson Services Inc. - Segment focus
Exhibits 124: Novartis AG - Overview
Exhibits 125: Novartis AG - Business segments
Exhibits 126: Novartis AG - Key news
Exhibits 127: Novartis AG - Key offerings
Exhibits 128: Novartis AG - Segment focus
Exhibits 129: Pfizer Inc. - Overview
Exhibits 130: Pfizer Inc. - Product / Service
Exhibits 131: Pfizer Inc. - Key news
Exhibits 132: Pfizer Inc. - Key offerings
Exhibits 133: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits 134: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits 135: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits 136: Sumitomo Pharma Co. Ltd. - Overview
Exhibits 137: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits 138: Sumitomo Pharma Co. Ltd. - Key news
Exhibits 139: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits 140: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits 141: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 142: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 143: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 144: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 145: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 146: Inclusions checklist
Exhibits 147: Exclusions checklist
Exhibits 148: Currency conversion rates for US$
Exhibits 149: Research methodology
Exhibits 150: Information sources
Exhibits 151: Data validation
Exhibits 152: Validation techniques employed for market sizing
Exhibits 153: Data synthesis
Exhibits 154: 360 degree market analysis
Exhibits 155: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global allergy relieving eye drops market: AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Dr Reddys Laboratories Ltd., Johnson and Johnson Services Inc., Lupin Ltd., Nicox S.A., Novartis AG, Ocular Therapeutix Inc, Pfizer Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co. Ltd, Rynel Clifton Pharma Pvt. Ltd., Santen Pharmaceutical Co. Ltd., Similasan Corp. USA, Starpharma Holdings Ltd, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing adoption of generics."

According to the report, one of the major drivers for this market is the high prevalence and incidence of eye infections.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Dr Reddys Laboratories Ltd.
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • Nicox S.A.
  • Novartis AG
  • Ocular Therapeutix Inc
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • ROHTO Pharmaceutical Co. Ltd
  • Rynel Clifton Pharma Pvt. Ltd.
  • Santen Pharmaceutical Co. Ltd.
  • Similasan Corp. USA
  • Starpharma Holdings Ltd
  • Sumitomo Pharma Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.